OpenAlex
PricingAboutJobs
Log inGet started
Work

A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA

HTML

Year: 2004
Type: article
Source: International Journal of Oncology
DOI: 10.3892/ijo.25.3.571
Authors: Tomohiro Emura, Norihiko Suzuki, Masahiro Yamaguchi, Hideyuki Ohshimo, Masakazu Fukushima
Institution: Taiho Pharmaceutical (Japan)
Language: English

Topic: Cancer therapeutics and mechanisms
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: trifluorothymidine, thymidine phosphorylase inhibitor, 5-fluorouracil resistance, DNA incorporation, DNA fragmentation, thymidylate synthase inhibition, thymidine phosphorylase, anticancer activity, colorectal cancer, pancreatic cancer, esophageal cancer
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2025641756
FWCI: 0.702
Cites:
Cited by: 128
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security